Drug purchasing list may not be reported

Published: 1999-12-28 17:04:00

Updated: 1999-12-28 17:04:00

The actual purchasing price reimbursement system launched from Nov. 15 seems to waver. In the meeting with the KMA and the KPhA on Dec. 22 the MOHW partly accepted proposals requested by the KMA and the KPhA and decided that the compulsory report of insurance drug purchasing list by the primary m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK